机译:A Retrospective Analysis of Clinical Biomarkers for Olaparib Maintenance Therapy in Patients with Recurrent Ovarian Cancer
Tohoku University,Tohoku Univ;
homologous recombination deficiency; olaparib; PARP inhibitor; progression free survival; recurrent ovarian cancer; SEROUS OVARIAN; SECONDARY BRCA1; RESISTANCE; MUTATIONS; CHEMOTHERAPY; DEFICIENCY; WOMEN;